chr5-42801261-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005410.4(SELENOP):c.605C>T(p.Ser202Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000853 in 1,614,022 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005410.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SELENOP | NM_005410.4 | c.605C>T | p.Ser202Leu | missense_variant | Exon 5 of 5 | ENST00000514985.6 | NP_005401.3 | |
CCDC152 | NM_001134848.2 | c.*1480G>A | 3_prime_UTR_variant | Exon 9 of 9 | ENST00000361970.10 | NP_001128320.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SELENOP | ENST00000514985.6 | c.605C>T | p.Ser202Leu | missense_variant | Exon 5 of 5 | 1 | NM_005410.4 | ENSP00000420939.1 | ||
CCDC152 | ENST00000361970.10 | c.*1480G>A | 3_prime_UTR_variant | Exon 9 of 9 | 1 | NM_001134848.2 | ENSP00000354888.5 |
Frequencies
GnomAD3 genomes AF: 0.000605 AC: 92AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000539 AC: 134AN: 248390Hom.: 0 AF XY: 0.000541 AC XY: 73AN XY: 134932
GnomAD4 exome AF: 0.000879 AC: 1285AN: 1461770Hom.: 2 Cov.: 33 AF XY: 0.000811 AC XY: 590AN XY: 727190
GnomAD4 genome AF: 0.000604 AC: 92AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000551 AC XY: 41AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.605C>T (p.S202L) alteration is located in exon 5 (coding exon 4) of the SEPP1 gene. This alteration results from a C to T substitution at nucleotide position 605, causing the serine (S) at amino acid position 202 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at